You are here

Article Text

Article menu
Download PDFPDF
Commentary
Akkermansia muciniphila derived tripeptide jams the gear of sepsis, inflammation and mortality

https://doi.org/10.1136/gutjnl-2023-331092

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors All authors contributed equally to the discussion, writing, correction and drawing of the figure.

    • Competing interests PDC is inventor on patent applications dealing with the use of specific bacteria and components in the treatment of different diseases. PDC was cofounder of The Akkermansia Company SA and Enterosys S.A.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles

    • Gut microbiota
      Novel tripeptide RKH derived from Akkermansia muciniphila protects against lethal sepsis
      Shihao Xie Jiaxin Li Fengyuan Lyu Qingming Xiong Peng Gu Yuqi Chen Meiling Chen Jingna Bao Xianglong Zhang Rongjuan Wei Youpeng Deng Hongzheng Wang Zhenhua Zeng Zhongqing Chen Yongqiang Deng Zhuoshi Lian Jie Zhao Wei Gong Ye Chen Ke-Xuan Liu Yi Duan Yong Jiang Hong-Wei Zhou Peng Chen
      Gut 2023; 73 78-91 Published Online First: 08 Aug 2023. doi: 10.1136/gutjnl-2023-329996